Bethel College supports the guidelines provided by the American College Health Association (ACHA) and the Advisory Committee on Immunization Practices (ACIP). The following immunizations are required at Bethel College and verified proof must be submitted prior to class attendance.
- Measles, Mumps, Rubella (MMR)
Two doses of MMR at least 28 days apart after 12 months of age
- Diphtheria, Tetanus, Pertussis (DPT)
Primary childhood series of 4 doses
- Tetanus, Diphtheria (Td) or Tetanus, Diphtheria, Acellular Pertussis (Tdap)
One Td booster every 10 years.
One Tdap for all college students regardless of interval since last Td booster
- Polio Vaccine (OPV or IPV)
Primary childhood series; IPV booster only if needed for travel after age 18 years
- Meningococcal Quadrivalent (A,C,Y,W-135)
Initial dose of conjugate vaccine:11-12 years of age with booster dose: 16 years of age
If initial dose given age 13-15 years: booster dose at 16-18 years of age
If initial dose given >16 years, no booster dose required
- Varicella (Chickenpox)
If no history of disease, 2 doses one month apart.
- Hepatitis B
Series of three doses given at 0,1, and 6 months apart
- Hepatitis A
Series of two doses given at 0 and 6 months apart
Students going abroad for study or Task Force teams may need travel vaccines. You may call the Saint Joseph Health Department Mishawaka Clinic at 574.256.6230 to make an appointment and inquire about costs.
Plan to begin the vaccination process at least six weeks before leaving.
For further information see www.cdc.gov/travel for recommended vaccines.
Tuberculosis Screening (TB)
This is not a vaccine. Proof of a TB test is needed within 6 months before attending classes if the student is considered in a high-risk category. Tine tests will not be accepted; only PPD (Mantoux) tests are acceptable. PPD tests are required regardless of prior BCG inoculation. A positive (TB) test will require a chest X-ray and evaluation for medication.
The American College Health Association has published guidelines on (TB) screening of college and university students. These guidelines are based on recommendations from the Centers for Disease Control and the American Thoracic Society. For more information visit www.acha.org or www.cdc.gov/nchstp/tb/pubs/corecurr
Categories of high-risk students include
- Students who have arrived within the past five years from countries where (TB) is endemic. It is easier to identify countries of low rather than high (TB) prevalence. Therefore students should undergo (TB) screening unless they have arrived from the following countries: Albania, Andorra, Antigua and Barbuda, Australia, Austria, Bahamas, Barbados, Belgium, British Virgin Islands, Canada, Chile, Costa Rica, Cuba, Cyprus, Czech Republic, Denmark, Dominica, Egypt, Fiji, Finland, France, Germany, Greece, Grenada, Hungary, Iceland, Iran (Islamic Republic of), Ireland, Israel, Italy, Jamaica, Jordan, Lebanon, Luxembourg, Malta, Mexico, Nauru, Netherlands, New Zealand, Norway, Oman, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Samoa, Saudi Arabia, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States of America, West Bank and Gaza Strip.
- Those infected with HIV.
- Intravenous drug users.
- Persons who have resided in, volunteered in, or worked in high risk congregate settings such as prisons, nursing homes, hospitals, residential facilities for persons with AIDS, and homeless shelters.
- Those with conditions such as diabetes, chronic renal failure, leukemia, lymphoma, low body weight, gastric bypass and similar stomach or intestinal surgeries, chronic malabsorption syndromes, prolonged corticosteroid therapies or other immunosuppressive disorders.
*The information provided in this website is for educational and informational use only. It does not provide medical or psychological advice and is not intended to replace the services of a trained medical or psychological professional. Please discuss health and mental health concerns with your healthcare provider.